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Abstract 
Macromolecules undergo changes with time and condition thereby affecting the structural 
and functional properties. These sequential and structural changes can be enumerated by 
comparative methods using the sequences and structural models. Molecular dynamics 
simulations are used to investigate dynamics and interactions of proteins in aqueous solution. We 
have studied the sequential variations in HIV-1 Trans-activating regulatory protein (Tat) among 
different strains and isolates taken from different geographical areas. Then these variations are 
modeled in consensus structures, so that each of the disparity can be suitably studied. Molecular 
dynamics simulation is carried out on each of these models to study the residual motions and 
interaction fluctuations. The results are compared and the functional implications of each of 
these transforms are studied.  We have identified intra molecular interactions of importance for 
structure stabilization. The results show the functional characteristics of the protein or part of it is 
precisely reflected in its structural interactions and molecular dynamics flexibility. 
Key words: Modeling, Molecular dynamics simulation, NAMD, Modeller, CHARMM, Tat, 
TAR RNA, Hydrogen interaction, RMSD. 
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Chapter 1 
1. Introduction 
Human immunodeficiency virus (HIV) is a retrovirus that causes acquired 
immunodeficiency syndrome (AIDS).  The life cycle of HIV inside the human host is 
complex and precise consisting many macromolecular interactions and activations. Each 
function is the window to next function performing role of molecular check point. 
Inhibiting one step effects the next impeding the cycle of viral replication and 
propagation [1]. One of such interaction between trans-activator of transcription (Tat) and 
transactivation responsive (TAR) region is responsible for initiation of transcription of 
viral RNA [2]. The interaction is vital for viral replication and propagation. The Tat 
protein suitably attaches itself to the TAR RNA hairpin structure to initiate the process. 
As the structural properties of the macromolecules involved guide the functional features 
carrying out the interaction, the three dimensional structure of both Tat and TAR is 
important for proper activation. 
 Macromolecules undergo changes with time and condition thereby affecting the 
structural and functional properties. The changes are due to various environmental 
conditions or process anomalies. These sequential and structural changes can be 
enumerated by comparative methods using the sequences and structural models. 
Molecular dynamics simulations are used to investigate dynamics and interactions of 
proteins in aqueous solution. We have considered the both of the above circumstances. 
First we have discussed the variability of the protein and incorporated these variabilities 
while modeling consensus structures based on a common template. In the second part we 
have done a dynamics study of these changes while keeping in mind the functional and 
conformational role they carry out in normal biochemical circumstances. In this way we 
have studied the importance of structural positions and their changes in a comparative 
manner. 
HIV shows a high rate of variation in its genome. The virus differs significantly 
among its subgroups, generations, geographical area and with time. There is also a 
definite change in carrying out the function of the virus with these alterations. This is one 
of the major reasons for the failure of developing a drug against the HIV, as a drug 
effective for one group may not act against the other. Finding a constant feature both in 
macromolecular structure and life cycle of the virus is important for developing strategies 
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against the virus. The sequential and structural variations have to be studied for pointing 
out these constant features. 
We have studied the sequential variations in HIV-1 TAR RNA element and Tat 
among different strains and isolates taken from different geographical areas. As the 
sequences are taken from different geographical areas they show variations in sequence 
and structure. Then these variations are modeled in consensus structures, so that each of 
the disparity can be suitably studied. Though the models are similar they differ in 
residues at important positions. Structures are compared at each segment and the 
structural aspect of each residual change is observed. Molecular dynamics simulation is 
carried out on each of these protein models to study the residual motions and interaction 
fluctuations with time. The results are compared and the functional implications of each 
of these transforms are studied.  We have identified importance of intra molecular 
interactions for structure stabilization. The results show the functional characteristics of 
the protein or part of it are precisely reflected in its structural interactions and molecular 
dynamics flexibility. 
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Chapter 2 
2. Literature review 
2.1. Human immunodeficiency virus (HIV) 
The first case of AIDS was first detected on June 5, 1981, when the U.S. Centers for 
Disease Control and Prevention reported a cluster of Pneumocystis pneumonia caused by 
a form of Pneumocystis carinii, now recognized as a distinct species Pneumocystis 
jirovecii, in five homosexual men in Los Angeles [3]. In 1982, the CDC introduced the 
term AIDS to describe the newly recognized syndrome. 
  In 1983, scientists led by Luc Montagnier at the Pasteur Institute in France first 
iosolated the virus that causes AIDS. They called it lymphadenopathy-associated virus 
(LAV) [4]. A year later a team led by Robert Gallo of the United States confirmed the 
discovery of the virus, but they renamed it human T lymphotropic virus type III (HTLV-
III) [5]. In 1986 the virus was named human immunodeficiency virus (HIV) [6]. Infection 
with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast 
milk. Within these bodily fluids, HIV is present as both free virus particles and virus 
within infected immune cells. The three major routes of transmission are unprotected 
sexual intercourse, contaminated needles, and transmission from an infected mother to 
her baby at birth, or through breast milk [7]. 
HIV was classified as a member of the genus Lentivirus, part of the family of 
Retroviridae [8]. Lentiviruses have many common morphologies and biological 
properties. Many species are infected by lentiviruses, which are characteristically 
responsible for long-duration illnesses with a long incubation period. Lentiviruses are 
transmitted as single-stranded, positive-sense, enveloped RNA viruses. Upon entry of the 
target cell, the viral RNA genome is converted to double-stranded DNA by a virally 
encoded reverse transcriptase that is present in the virus particle. This viral DNA is then 
integrated into the cellular DNA by a virally encoded integrase so that the genome can be 
transcribed. Once the virus has infected the cell, two pathways are possible: either the 
virus becomes latent and the infected cell continues to function, or the virus becomes 
active and replicates, and a large number of virus particles are liberated that can then 
infect other cells [9].   
          HIV primarily infects vital cells in the human immune system such as helper T 
cells (specifically CD4+ T cells), macrophages and dendritic cells. HIV infection leads to 
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low levels of CD4+ T cells through three main mechanisms: firstly, direct viral killing of 
infected cells; secondly, increased rates of apoptosis in infected cells; and thirdly, killing 
of infected CD4+ T cells by CD8 cytotoxic lymphocytes that recognize infected cells. 
When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, 
and the body becomes progressively more susceptible to opportunistic infections. If 
untreated, eventually most HIV-infected individuals develop AIDS and die [10, 1, 7]. But 
the prognosis may be varied with viral starins. 
2.1.1. Structure of the HIV 
 The virus is roughly spherical with spikes on the surface. The outer layer consists 
of the prospholipid viral envelope. Many copies of a complex HIV protein protrude 
through the surface of the virus particle. This protein, known as Env, consists of a cap 
made of three molecules called glycoprotein (gp) 120, and a stem consisting of three 
gp41 molecules that anchor the structure into the viral envelope. The underneath matrix 
layer consists up of protein p17. The inner capsid layer which encompasses the two 
positive single stranded RNA structures and enzymes such as reverse transcriptase, 
protease, integrase is made up of p24 proteins. The structure of the HIV is shown in 
Figure-1. 
 
 
Figure-1: Structure of Human Immunodefficiency Virus 
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2.1.2. Genes  
The HIV genome show nine genes and several structural elements. Out of these 
nine genes gag, pol, and env, contain information needed to make the structural proteins 
for new virus particles. The six remaining genes, tat, rev, nef, vif, vpr, and vpu (or vpx in 
the case of HIV-2), are regulatory genes for proteins that control viral replication and 
propagation [11]. The genetic organization of the virus is shown in figure-2. 
The gag gene encodes the capsid proteins (group specific antigens). The precursor 
is the p55 myristylated protein, which is processed to p17 (Matrix), p24 (Capsid), p7 
(NucleoCapsid), and p6 proteins, by the viral protease. Gag associates with the plasma 
membrane where the virus assembly takes place [12]. The pol genomic region encodes 
the viral enzymes protease, reverse transcriptase and integrase. These enzymes are 
produced as a Gag-Pol precursor polyprotein, which is processed by the viral protease 
[13]. The Gag-Pol precursor is produced by ribosome frameshifting near the 3' end of 
gag. The env genes give the proteins those are embedded in the outer layer of the virus. 
Viral glycoproteins produced as a precursor (gp160) which is processed to give a 
noncovalent complex of the external glycoprotein gp120 and the transmembrane 
glycoprotein gp41. gp120 contains the binding site for the CD4 receptor, and the seven 
trans-membrane domain chemokine receptors that serve as co-receptors for HIV-1 [14].  
Tat is one of the two essential viral regulatory factors for HIV gene expression. 
Two forms are known, Tat-1 exon (minor form) of 72 amino acids and Tat-2 exon (major 
form) of 86 amino acids. Low levels of both proteins are found in persistently infected 
cells. Tat has been localized primarily in the nucleolus by immunofluorescence. It acts by 
binding to the TAR RNA element and activating transcription initiation and elongation 
from the LTR promoter, preventing the 5' LTR AATAAA polyadenylation signal from 
causing premature termination of transcription and polyadenylation. It is the first 
eukaryotic transcription factor known to interact with RNA rather than DNA and may 
have similarities with prokaryotic anti-termination factors. Extracellular Tat can be found 
and can be taken up by cells in culture [15].  Rev is the second necessary regulatory 
factor for HIV expression [16]. A 19 kD phosphoprotein, localized primarily in the 
nucleolus or nucleus, Rev acts by binding to RRE (Rev regulatory element) and 
promoting the nuclear export, stabilization and utilization of the viral mRNAs containing 
RRE. Rev is considered the most functionally conserved regulatory protein of 
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lentiviruses. Rev cycles rapidly between the nucleus and the cytoplasm. Viral infectivity 
factor (vif) is a basic protein of typically 23 kD. It promotes the infectivity but not the 
production of viral particles. In the absence of Vif the produced viral particles are 
defective, while the cell-to-cell transmission of virus is not affected significantly. Found 
in almost all lentiviruses, Vif is a cytoplasmic protein, existing in both a soluble cytosolic 
form and a membrane-associated form. The latter form of Vif is a peripheral membrane 
protein that is tightly associated with the cytoplasmic side of cellular membranes [17].  
 
Figure-2: Genetic organization of HIV 
Vpr (viral protein R) is a 96-amino acid (14 kD) protein, which is incorporated 
into the virion. It interacts with the p6 Gag part of the Pr55 Gag precursor. Vpr detected 
in the cell is localized to the nucleus. Proposed functions for Vpr include the targeting the 
nuclear import of preintegration complexes, cell growth arrest, transactivation of cellular 
genes, and induction of cellular differentiation. In HIV-2 and SIV the Vpx gene is 
apparently the result of a Vpr gene duplication. Vpu (viral protein U) is unique to HIV-1, 
SIVcpz. There is no similar gene in HIV-2. Vpu is a 16-kd (81-amino acid) type I integral 
membrane protein with at least two different biological functions: (a) degradation of CD4 
in the endoplasmic reticulum, and (b) enhancement of virion release from the plasma 
membrane of HIV-1-infected cells [11]. Nef is a multifunctional 27-kd myristylated 
protein produced by an ORF located at the 3' end of the primate lentiviruses. Nef is 
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predominantly cytoplasmic. One of the first HIV proteins to be produced in infected 
cells; it is the most immunogenic of the accessory proteins. Nef is necessary for the 
maintenance of high virus load. Nef down regulates CD4, the primary viral receptor, and 
MHC class I molecules. It increases viral infectivity [18].  
2.2. Genetic variability 
Human immunodeficiency virus type 1 (HIV-1), which is a member of the 
Lentivirus genus (family Retroviridae), is characterized by a high level of genetic 
variation [19]. Members of Retroviridae are RNA viruses that replicate through a DNA 
intermediate. The viral RNA is copied into DNA by the viral enzyme reverse 
transcriptase. This process is quite error prone and forms the basis for the high genetic 
variability of these viruses. However, the observed genetic variation is a product of a 
complicated process influenced by many factors, most notably mutation and selection. 
The mutation rate of reverse transcriptase has been suggested to be 3.4 X 1025 mutations 
per base pair per replication cycle in vivo. In addition, the rate of genetic recombination 
in retroviruses is high, and this greatly contributes to the genetic variation. The apparent 
substitution rates across the genome are not the same, as illustrated by the presence of the 
five variable regions (V1 to V5) in the HIV-1 env gene [20].  
Unlike bacterial genomes, the HIV-1 genome is A rich (36%) and C poor (18%). 
In vertebrates, the base composition varies between genes, and it has been suggested that 
the mosaic structure of the chromosomes reflects the varying G+C content [21]. Because 
of varying G+C content, the codon usage of a gene may vary with its genomic G+C 
context. It has been reported that HIV codon usage is dramatically different from that of 
cellular genes due to a high preference for A-rich codons and that this also results in a 
biased amino acid com-position of viral proteins. Furthermore, HIV-1 has been shown to 
produce extensive and monotonous G-to-A nucleotide substitutions, especially in the 
GpA dinucleotide. It has been suggested that a biased dCTP pool during reverse 
transcription is the cause of the G-to-A hyper mutation.  
This variability is compounded when a single cell is simultaneously infected by 
two or more different strains of HIV. When simultaneous infection occurs, the genome of 
progeny virions may be composed of RNA strands from two different strains. This hybrid 
virion then infects a new cell where it undergoes replication. As this happens, the reverse 
transcriptase, by jumping back and forth between the two different RNA templates, will 
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generate a newly synthesized retroviral DNA sequence that is a recombinant between the 
two parental genomes. This recombination is most obvious when it occurs between 
subtypes [22].  
          Two species of HIV infect humans: HIV-1 and HIV-2. HIV-1 is thought to have 
originated in southern Cameroon after jumping from wild chimpanzees to humans. HIV-2 
may have originated from the Sooty mangabeys, an old world monkey of Guinea-Bissau, 
Gabon, and Cameroon. HIV-1 is more virulent. It is easily transmitted and is the cause of 
the majority of HIV infections globally. HIV-2 is less transmittable and is largely 
confined to West Africa. HIV-1 is the virus that was initially discovered and termed 
LAV. The genetic sequence of HIV-2 is only partially homologous to HIV-1 and more 
closely resembles that of SIV than HIV-1 [7, 23]. 
2.3. Genomic diversity of clades 
           Three groups of HIV-1 have been identified on the basis of differences in env 
namely M, N, and O [24]. Group M is the most prevalent and is subdivided into eight 
subtypes (or clades), based on the whole genome, which are geographically distinct. The 
most prevalent are subtypes B (found mainly in North America and Europe), A and D 
(found mainly in Africa), and C (found mainly in Africa and Asia). These subtypes form 
branches in the phylogenetic tree representing the lineage of the M group of HIV-1.Co 
infection with distinct subtypes gives rise to circulating recombinant forms (CRFs) [25]. 
 HIV-1 clades are phylogenetically classified on the basis of the 20–50% 
differences in envelope (env) nucleotide sequences. The Env proteins of groups M and O 
may differ by as much as 30–50% [26]. The N subtype, in turn, appears to be 
phylogenetically equidistant from M and O. Within M subgroups, inter-clade env 
variations differ by 20–30% whereas intra clade variation of 10–15% is observed. The 
pol region of HIV-1 is two to three times less divergent than env because this region 
encodes two critically important enzymes, reverse transcriptase and protease, which, if 
excessively mutated, render the virus inoperative. gag sequences are even further 
intolerant of mutations, seeing as they encode for relatively inflexible core protein 
sequences. Inter- and intra-clade variations within pol sequences are particularly relevant 
insofar as this region encodes reverse transcriptase and protease proteins, against which 
many antiviral drugs are directed. Variations in these regions may therefore affect drug 
susceptibility and development of drug resistance. 
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          High degree of sequence variability is sufficient to alter the antigenic and 
biological properties of members of this virus group significantly [27]. The 
immunoreactive region of the gag protein is highly variable so that most epitopes are 
type-specific. This leads to a substantial reduction in the effectiveness of antibody assays 
based on this protein for serological diagnosis of infection with divergent HIV types. 
Variability in the envelope region is even greater so that neutralizing antibodies might be 
type-specific and allow multiple infections with different HIV variants in re-exposed 
individuals.  
2.4. Drug and vaccine design 
             HIV differs from many other viruses as it has very high genetic variability. This 
diversity is a result of its fast replication cycle, with the generation of 109 to 1010 virions 
every day, coupled with a high mutation rate of approximately 3 x 10-5 per nucleotide 
base per cycle of replication and recombinogenic properties of reverse transcriptase. This 
complex scenario leads to the generation of many variants of HIV in a single infected 
patient in the course of one day. A significant challenge in the global effort to develop a 
vaccine against human immunodeficiency virus type 1 (HIV-1) is the extensive genetic 
variation observed among viral strains from different countries [28].  
 Many studies were performed to facilitate the design of an efficacious anti-HIV-1 
vaccine by epitope based identification of CTL rich regions across HIV-1C Gag, Tat, 
Rev, and Nef [28, 29]. Hypothetically, an ideal HIV vaccine would contain multiple, 
highly responsive epitopes (CTL, T-helper, and neutralizing) derived from the locally 
circulating viral strains that cumulatively and complementarily would protect the host 
from HIV-1 infection, or, as a more realistic goal, could control HIV-1 infection, prevent 
progression to AIDS, and diminish HIV-1 transmission rate . 
 Phylogenetic analysis has shown that HIV-1 sequences can be classified into three 
main groups designated M, O, and N. Group M viruses are responsible for the majority of 
HIV-1 infections in the world and can be subdivided into subtypes A through D, F, G, H, 
J, K, and circulating recombinant forms (CRFs). Genetic subtypes show differences of as 
much as 24% in amino acid sequence, which raises the possibility that a vaccine 
candidate developed from one subtype may not be equally efficacious for other subtypes 
[30].  
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          Elucidation of the phylogenetic origins of simian and human immunodeficiency 
viruses (SIV and LIV) is fundamental to the understanding of HIV pathogenesis and the 
spread of AIDS worldwide. Lentiviruses similar to human immunodeficiency viruses 
(HIVs) have been identified in a wide range of African primates including mangabeys 
(Cercocebus), guenons (Cercopithecus), mandrills (Papio) and chimpanzees (Pan) [31]. 
Although related to HIV in their physical structure, genetic composition and replicative 
properties, these simian immunodeficiency viruses SIV differ from the human AIDS 
viruses in one fundamental aspect of their biology: they fail to induce clinical 
immunodeficiency in their natural hosts. Understanding the molecular biology of these 
viruses, their lack of pathogenicity despite persistent replication and the processes 
responsible for their adaptation to a natural host may thus be important for achieving a 
better understanding of the virulence of HIV in man and the mechanisms underlying 
AIDS pathogenesis [32, 33].  
 Comparative analysis of TAR RNA structures in human and simian 
immunodeficiency viruses reveals the conservation of certain structural features despite 
the divergence in sequence [34]. Both the TAR elements of HIV-1 and SIV-chimpanzee 
can be folded into relatively simple one-stem hairpin structures. Chemical and RNAase 
probes were used to analyze the more complex structure of HIV-2 TAR RNA, which 
folds into a branched hairpin structure. A surprisingly similar RNA conformation can be 
proposed for SIV-mandrill, despite considerable divergence in nucleotide sequence. A 
third structural presentation of TAR sequences is seen for SIV-african green monkey. 
These results are generally consistent with the classification of HIV-SIV viruses in four 
subgroups based on sequence analyses (both nucleotide- and amino acid-sequences). 
However, some conserved TAR structures were detected for members of different virus 
subgroups. RNA structure analysis might provide an additional tool for determining 
phylogenetic relationships among the HIV-SIV viruses. 
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Figure-3: Phylogenetic Tree of the SIV and HIV viruses. 
 
 
Figure-4: Subtype diversity of HIV-1 infections prevalent worldwide [27]. 
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2.5. RNA Structure and Binding affinity 
              The functional diversity of RNA reflects diversity in its three-dimensional 
structure. Knowledge of the three-dimensional structures and general rules for RNA 
folding will be invaluable for deducing more detailed mechanisms of all RNA functions 
[35]. In the absence of high-resolution data, robust phylogenetic methods were developed 
to obtain secondary structure, and ingenious biochemical experiments were used to define 
nucleotide accessibility and to detect long range tertiary interactions [36]. RNA is 
nowadays the only molecule with the two properties of being a depository of genomic 
information with catalytic potential. Chemical catalysis requires a precise positioning of 
atoms in space and, therefore, RNA must achieve complex tertiary folds in order to reach 
transition states [37]. 
Binding of proteins and ligands to the RNA motif is purely based on the structure. 
Binding affinity of the components which defines stability of the complex is dependent 
on binding energy. This binding energy is a function of structure, charge and temperature 
(entropy). RNA sequences contain signatures specific for three dimensional motifs which 
participate in recognition and binding [38]. In regulatory pathways, RNA molecules exist 
in equilibria between transient structures differentially stabilized by effectors such as 
proteins or cofactors. Therefore, RNA molecules display their potential as drug targets on 
different levels, namely in three-dimensional folds, in structural equilibria and in RNA-
protein interfaces [39].  
             The investigation of ligand-RNA interactions by computational approaches is 
dependent on the availability of three-dimensional models of RNA targets based on X-
ray, NMR or phylogenetic data. Enormous progress in RNA synthesis and structure 
determination methods have helped to overcome many of the difficulties in obtaining 
NMR or crystal structures of RNA [40]. 
2.6. TAR-Tat interaction 
The HIV trans-activating regulatory protein (Tat) protein carries out efficient 
transcriptional activation of viral long terminal repeat-linked genes by binding an RNA 
target structure termed TAR [1]. Tat-mediated trans-activation largely operates by 
increasing elongation efficiency of nascent transcripts or coordinating initiation and 
elongation from the HIV long terminal repeat (LTR). Presence of Tat protein is required 
for the total transcription, in the absence of which the short transcripts predominates [2, 
13 
 
41]. Deletion analysis of the viral LTR showed that the genetic element responsible for 
Tat activity, the trans-activation responsive region (TAR), is generally located 
downstream of the initiation site for transcription nucleotides +1 and +59 [15]. It also 
interacts with the Cyclin T1 (CycT1) subunit of the positive transcription elongation 
factor complex, P-TEFb inducing co-operative binding of the P-TEFb complex onto 
nascent HIV-1 TAR RNA [42]. 
The simplest explanation for the nature of Tat to activate transcription from viral 
LTRs that carry TAR elements is that Tat binds directly to TAR RNA. After purification 
of recombinant Tat it is demonstrated that it is able to specially recognize TAR RNA 
[43]. Subsequently, it was noted that synthetic peptides carrying the basic domain of Tat 
are also able to bind directly to TAR RNA [44]. 
Despite extensive efforts, the crystals of HIV-1 Tat have not been obtained [15]. 
The best information about the three-dimensional structure of Tat is based on nuclear 
magnetic resonance (NMR) [45, 46]. The Tat sequence can be subdivided into several 
distinct regions on the basis of its amino acid composition and the nature of its role in 
basic function [47, 48]: a N-terminal activation region (NT, amino acids 1–19), a 
cysteine-rich core domain (CRD, amino acids 20–31), a core region (amino acids 32–47), 
a arginine rich RNA binding domain (ARD, amino acids 48-57), a glutamine-rich region 
(QRD, amino acids 58–76) and the C-terminal (CT, amino acids 77-86).  
           The RNA binding property is clearly reflected in the structure of Tat protein. The 
core, basic and glutamine rich region are all involved in RNA binding. The recent NMR 
studies of HIV [47] and equine infectious anemia virus (EIAV) [49] Tat proteins show a 
compact core structure and the close proximity between the N terminus and the basic 
region. Addition of the core region of Tat to basic polypeptide mimics of Tat leads to 
enhanced binding and a considerable improvement in the quality of the NMR spectra 
[48]. This shows the binding affinity of Tat protein and in particular the basic region 
towards the TAR RNA. 
Binding is mediated by a ten amino acid basic domain that is rich in arginine and 
lysines [50]. Circular dichroism and two-dimensional proton NMR studies of this hybrid 
peptide indicate that the Tat basic domain forms a stable α-helix, whereas the adjacent 
regulatory sequence is mostly in extended form. These findings suggest that the tendency 
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to form stable α-helices may be a common property of arginine and lysine rich RNA 
binding domains [51].  
 Interactions and participating macromolecules undergo modification in relation to 
time, condition and genomic strength of the organism [52]. Enumerating characteristics 
and attributes to quantify these modifications is essential for quantifying these changes, 
both structural and functional. Mathematical and computational tools can be useful for 
analyzing these changes in interaction and its effect on viral lifecycle. Molecular 
dynamics simulation is used in various studies to find out structural [54], binding [56, 99, 
100] and functional properties of various systems like protein [54, 98], protein-ligand 
complex [99, 56] and membrane molecules [96, 97]. Molecular dynamics is used in 
defining the binding pathways of proteins with other macro molecules [101, 102].  
Similarly several dynamics studies have been done taking Tat protein alone or complex 
with TAR RNA element or other macromolecules [53, 54]. The studies show the 
dynamics and intermolecular interaction among the different region of the protein [54]. 
These studies also demonstrate the relationship between the residual motion and 
functional role of the residue. The molecular dynamics study also shows the flexibility of 
both TAR RNA and basic arginine rich peptide while forming a complex [55, 56]. An 
interdomain motion is observed in the simulation of free TAR, which is absent in the case 
of bound TAR, leading to the conclusion that the free conformation of TAR is 
intrinsically more flexible than the bound conformation. Free energy analysis, which 
includes salvation contributions, was used to evaluate the influence of van der Waals and 
electrostatic terms on formation of the complex and on the conformational rearrangement 
from free to bound TAR [56]. Reyes et. al have investigated the differences in previously 
studied structures and trajectories, particularly in the formation of the U-A-U base triple, 
the dynamic flexibility of the Tat peptide, and the interactions at the binding interface. 
They have also calculated the relative binding of different Tat peptide mutants to TAR 
RNA and found qualitative agreement with experimental studies. The molecular 
dynamics simulations show that the starting structures in which KkN binds to the major 
groove of TAR (as it is the case for the Tat-TAR complex of HIV-1) are unstable [53].  
Molecular dynamics simulation studies along with docking suggest that several attractive 
interactions between the native Tat (1-9) and dipeptidyl peptidase IV lead to a stable 
complex and that the reduced affinity of both L6-Tat (1-9) and I5-Tat (1-9) derivatives 
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might be caused by conformational alterations in comparison to the parent peptide [103]. 
In an attempt to shed light on the molecular basis of the functional differences found for 
Tat mutants a series of molecular dynamics simulations have performed on modified Tat 
proteins from HIV-1 strain Z2. Remarkable correlation is found between the degree of 
structure conservation and the transactivation capabilities of Tat mutants [104]. The 
studies illustrate the relation between structural dynamics of the protein and its residues 
with its function and activation. The nature of the dynamics is varied according to the 
residue position, sequence and structure. 
2.7. Molecular Phylogenetics 
Mutation takes place in genome of every organism. The single nucleotide shift is 
due to the insertion or deletion of the nucleotides. These mutations are randomly caused 
by error in the replication machinery and are essential for the natural selection process. 
By comparing the sequence of the genome (DNA) or the functional elements (RNA, 
protein) of different isolates or species conclusion about the evolutionary relationship, 
functional and structural variations can be drawn [57]. 
Molecular phylogenetic analysis detects evolutionary relationships among 
organisms. Phylogenetic trees can represent these relationships. A phylogenetic tree is a 
graph consisting of nodes and branches where only one branch connects any two adjacent 
nodes. The nodes represent the taxonomic unit. The algorithms use sequences of DNA, 
RNA or protein to construct the trees. These sequences are first prepared, shorted and 
aligned. The quality of these alignments affects the reliability of the tree. 
          The most commonly used methods to construct phylogenies include parsimony, 
maximum likelihood, and MCMC-based Bayesian inference [58]. Distance-based 
methods construct trees based on overall similarity which is often assumed to 
approximate phylogenetic relationships. All methods depend upon a mathematical model 
describing the evolution of characters observed in the species included. They are usually 
used for molecular phylogeny where the characters are aligned nucleotide or amino acid 
sequences. The use of phylogenetics in viral studies has increased dramatically in the last 
years. When estimating phylogenetic relationships among DNA sequences, the use of a 
model of nucleotide substitution is necessary. While maximum parsimony assumes a 
model of evolution in an implicit manner taking the number of mutation required to 
convert one sequence to another, distance methods and maximum likelihood explicitly 
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estimate parameters according to the model of evolution specified [59, 60]. Distance 
methods estimate only the substitution rate, while maximum likelihood estimates all the 
parameters of the model. Many viral evolutionary studies have focused on the HIV-1 
virus. Likewise, many genes show a bias in transitions over transversions, again affecting 
the rate of change from one nucleotide to another. 
          An important factor that affects the accuracy of tree reconstruction is whether the 
data analyzed actually contain useful phylogenetic signal, a term that is used generally to 
denote whether related organisms tend to resemble each other with respect to their 
genetic material or phenotypic traits [61, 62]. 
2.8. Structural Prediction 
             The experimental methods used for determining structure, including NMR and 
X-ray crystallography, are time consuming and can depend on initial secondary structure 
models for developing constructs. The structure can also be predicted computationally by 
inter relating various physical, chemical and mathematical rules, and considering various 
factors. Mathematical models and algorithms are needed for incorporating those rules 
into a physical structure. Parameters those define the structure have to be selected for 
creating these rules [63]. The methods devised for predicting the structure are 
comparative or homology modeling and ab initio method with computer algorithm. 
Comparative protein modelling uses previously solved structures as starting points, or 
templates. Ab initio- or de novo- protein modelling methods seek to build three-
dimensional protein models  based on physical principles rather than on previously 
solved structures. Structure is usually determined by the comparative analysis of multiple 
homologous sequences. When homologous sequences are not available, free energy 
minimization by dynamic programming can be used to predict the structure of a single 
sequence [64]. Till now homology modeling gives more accurate protein structures than 
any other method. 
2.8.1. Homology modeling 
             Comparative or homology modeling uses experimentally determined protein 
structures to predict the conformation of other proteins with similar amino acid 
sequences. Small changes in the sequences is accordingly reflected in the structure. Till 
now homology modeling remains most accurate method to predict the protein structure 
[65].  Although several procedures exist in the public domain, the choice of the right 
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method is not unambiguous. Study shows that Modeller gave best results amongst the 
chosen protocols [66]. Modeler produces protein homology models, given a template and 
sequence alignment. The structures are predicted based on distance restraints obtained 
from the template, from the database of crystal structures in the PDB, and from a 
molecular force field. Ligand structures and constraints such as disulfide bonds and cis-
prolines can be incorporated into the model building step. Loops are generated de novo, 
by a process that incorporates knowledge-based potentials from known crystal structures 
[67]. Homology modeling consists of building a protein model using a structural 
template, the template being a protein of known structure. The basic outline of the 
procedure is shown in Figure 5. The sequences of the two proteins, the target (or 
unknown) protein and the template, are first aligned. The Cα coordinates of the aligned 
residues from the template are then copied over to the target to form the skeletal 
backbone. The residue side chains, and relative insertions and deletions, are then modeled 
using automated or semi-automated procedures. Finally, the protein model thusly 
obtained may be subjected to energy minimization or molecular dynamics to relax 
unfavorable contacts. The quality of the sequence alignment is critical in determining 
model quality [68]. The quality of the homology model is dependent on the quality of the 
sequence alignment and template structure. The approach can be complicated by the 
presence of alignment gaps (commonly called indels) that indicate a structural region 
present in the target but not in the template, and by structure gaps in the template that 
arise from poor resolution in the experimental procedure (usually X-ray crystallography) 
used to solve the structure. Model quality declines with decreasing sequence identity; a 
typical model has ~2 Å agreement between the matched Cα atoms at 70% sequence 
identity but only 4-5 Å agreement at 25% sequence identity. Regions of the model that 
were constructed without a template, usually by loop modeling, are generally much less 
accurate than the rest of the model, particularly if the loop is long. Errors in side chain 
packing and position also increase with decreasing identity, and variations in these 
packing configurations have been suggested as a major reason for poor model quality at 
low identity [69]. 
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Figure-5: Outline of steps for homology modeling process. 
Molecular dynamics simulation 
Molecular dynamics (MD) is a form of computer simulation in which atoms and 
molecules are allowed to interact for a period of time under known laws of physics, 
giving a view of the motion of the atoms. Molecular dynamics probes the relationship 
between molecular structure, movement and function [70]. Molecular dynamics is a 
specialized discipline of molecular modeling and computer simulation based on statistical 
mechanics Computational methods have been used in biology for sequence analysis, all-
atom simulation, and more recently for modeling biological networks. Of these three 
techniques, all-atom simulation is currently the most computationally demanding, in 
terms of compute load, communication speed, and memory load [71]. The molecular 
dynamics method was first introduced by Alder and Wainwright in the late 1950's [70] to 
study the interactions of hard spheres. Many important insights concerning the behavior 
of simple liquids emerged from their studies. 
 Molecular dynamics simulations generate information at the microscopic level, 
including atomic positions and velocities. Statistical mechanics is required for the 
conversion of this microscopic information to macroscopic observables such as pressure, 
energy, heat capacities, etc. Statistical mechanics is fundamental to the study of 
biological systems by molecular dynamics simulation. In a molecular dynamics 
simulation, the macroscopic properties of a system is explored through microscopic 
simulations, for example, to calculate changes in the binding free energy of a particular 
ligand, or to examine the energetics and mechanisms of conformational change. The 
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connection between microscopic simulations and macroscopic properties is made via 
statistical mechanics which provides the rigorous mathematical expressions that relate 
macroscopic properties to the distribution and motion of the atoms and molecules of the 
N-body system. Molecular dynamics simulations provide the means to solve the equation 
of motion of the particles and evaluate these mathematical formulas. With molecular 
dynamics simulations, one can study both thermodynamic properties and/or time 
dependent (kinetic) phenomenon [72, 73, 74]. 
In molecular dynamic simulations the atoms of a system move according to the 
Newtonian equations of motion 
   
Where Fi is the force exerted on particle i, mi is the mass of particle i and ai is the 
acceleration of particle i. The force can also be expressed as the gradient of the potential 
energy, 
 	
 
Combining these two equations yields 
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Where Utotal is the potential energy of the system. Newton’s equation of motion 
can then relate the derivative of the potential energy to the changes in position as a 
function of time. 
 Highly simplified description of the molecular dynamics simulation algorithm is 
given in figure-6 [75]. The simulation proceeds iteratively by alternatively calculating 
forces and solving the equations of motion based on the accelerations obtained from the 
new forces. In practise, almost all MD codes use much more complicated versions of the 
algorithm, including two steps (predictor and corrector) in solving the equations of 
motion and many additional steps for e.g. temperature and pressure control, analysis and 
output. 
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Figure-6: Molecular dynamics simulation algorithm [75] 
2.9.1. Force Field Functions 
The potential energy, represented through the MD “force field,” is the most 
crucial part of the simulation because it must faithfully represent the interaction between 
atoms, yet be cast in the form of a simple mathematical function that can be calculated 
quickly. For an all-atom MD simulation, one assumes that every atom experiences a force 
specified by a model force field accounting for the interaction of that atom with the rest 
of the system. Today, such force fields present a good compromise between accuracy and 
computational efficiency. NAMD employs a common potential energy function that has 
the following contributions [105]: 
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Where bonds counts each covalent bond in the system, angles are the angles 
between each pair of covalent bonds sharing a single atom at the vertex, and dihedral 
describes atom pairs separated by exactly three covalent bonds with the central bond 
subject to the torsion angle Ø (Fig. 7). An “improper” dihedral term governing the 
geometry of four planar, covalently bonded atoms is also included as depicted in Figure-
7. The final two terms in equation describe interactions between nonbonded atom pairs, 
which correspond to the van der Waal’s forces (approximated by a Lennard–Jones 
potential) and electrostatic interactions, respectively. 
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Figure-7: Internal coordinates for bonded interactions: r governs bond stretching; θ 
represents the bond angle term; Ø gives the dihedral angle; the small out-of-plane angle α 
is governed by the so-called “improper” dihedral angle φ [105]. 
To avoid surface effects at the boundary of the simulated system, periodic 
boundary conditions are often used in MD simulations. The particles are enclosed in a 
cell that is replicated to infinity by periodic translations. A particle that leaves the cell on 
one side is replaced by a copy entering the cell on the opposite side, and each particle is 
subject to the potential from all other particles in the system including images in the 
surrounding cells, thus entirely eliminating surface effects. Because every cell is an 
identical copy of all the others, all the image particles move together and need only be 
represented once inside the molecular dynamics code. However, because the van der 
Waals and electrostatic interactions exist between every nonbonded pair of atoms in the 
system (including those in neighboring cells) computing the long-range interaction 
exactly is unfeasible. To perform this computation, the van der Waals interaction is 
spatially truncated at a user-specified cutoff distance. For a simulation using periodic 
boundary conditions, the system periodicity is exploited to compute the full 
(nontruncated) electrostatic interaction with minimal additional cost using the particle-
mesh Ewald (PME) method described in the next section. 
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2.9.2. Full Electrostatic Computation 
Ewald summation is a description of the long-range electrostatic interactions for a 
spatially limited system with periodic boundary conditions [106]. The infinite sum of 
charge-charge interactions for a charge-neutral system is conditionally convergent, 
meaning that the result of the summation depends on the order in which it is taken. Ewald 
summation specifies the order as follows: sum over each box first, then sum over spheres 
of boxes of increasingly larger radii. Ewald summation is considered more reliable than a 
cutoff scheme, although it is noted that the artificial periodicity can lead to bias in free 
energy, and can artificially stabilize a protein that should have unfolded quickly. 
Dropping the prefactor 1/4πε, the Ewald sum involves the following terms: 
EEwald = Edirect + Ereciprocal + Eself + Esurface 
The particle–mesh Ewald (PME) method is a fast numerical method to compute 
the Ewald sum [86]. The PME method does not conserve energy and momentum 
simultaneously, but neither does the particle-particle/particle-mesh method or the 
multilevel summation method. Momentum conservation can be enforced by subtracting 
the net force from the reciprocal sum computation, albeit at the cost of a small long-time 
energy drift. 
2.9.3. Numerical Integration 
Biomolecular simulations often require millions of time steps. Furthermore, 
biological systems are chaotic; trajectories starting from slightly different initial 
conditions diverge exponentially fast and after a few picoseconds are completely 
uncorrelated. However, highly accurate trajectories are not normally a goal for 
biomolecular simulations; more important is a proper sampling of phase space. 
Therefore, for constant energy (NVE ensemble) simulations, the key features of an 
integrator are not only how accurate it is locally, but also how efficient it is, and how well 
it preserves the fundamental dynamical properties, such as energy, momentum, time-
reversibility. 
       Designing drugs or vaccine against Human immunodeficiency virus has been facing 
failure due to the variability of the structural motifs against which the drugs are being 
designed. Motif with constant structural features across strains, time and geographical 
regions will be a very good target for which stable drugs or vaccines can be designed. 
Phyllogenetic analysis will be helpful in finding such structures across diversities. In 
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comparison to structural genes and proteins like env and gag, regulatory protein (tat, rev) 
and structural elements like TAR, RRE show more constancy in sequence and structure. 
Targeting RNA has some advantages as compared with targeting proteins. More sites are 
accessible at the RNA level; whereas the active site of a protein is often the only target. 
Proteins that share a common substrate like ATP or ligands are difficult to inhibit 
specifically. It is possible to develop multivalent drugs to target RNA or drugs that target 
a RNA sequence that is essential for encoding an important sequence of a protein. RNA 
elements TAR and RRE also have very conserve structural features which are effective 
binding site for tat and rev protein respectively. The binding of these two proteins to their 
respective elements is very crucial for replication and assembly of virus. Study of 
structure and binding properties with molecular dynamics simulation methods will help 
in designing strategies for inhibition of the virus spreading and migration. 
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Chapter 3 
3. Methods 
3.1. Sequence and alignment 
              The nucleotide and peptide sequences of the thirty two isolates described here 
are available under EMBL accession numbers. The sequences of the Tat protein are 
collected from Rfam database (http://www.sanger.ac.uk/cgi-bin/Rfam/) [76]. All 
sequences are manually checked for anomalies using Bioedit program. Residues from 
position 1 to 86 of the protein segment are only taken for alignment. Sequence variability 
is considered while choosing the sequences. The sequences are selected from different 
geographical regions and subgroups. A selective random approach was taken while 
deciding a sequence from the database. The description of the sequences are given in 
table-1. 
The selected HIV and SIV tat sequences were aligned using ClustalW with 
reference to Blossom-62 substitution matrix (http://www.ebi.ac.uk/clustalw) [77]. 
Distances between pairs of sequences were estimated using the Protdist program of the 
Phylip package provided by Dr J. Felsenstein. Consensus sequence was generated from 
the aligned sequences using cons program of Emboss package [78].  
  Residue wise comparison of the consensus sequence with the aligned sequences 
was carried out by Bioedit. Assignment of residues at each position was determined by 
comparing the residue frequency at the position in the aligned sequences and with that of 
structures available at protein data bank. Three sequences were generated on the basis of 
sequence based variation from the consensus sequence. The distance between the 
sequences are compared with Protdist provided in the Phylip package with reference to 
PAM matrix. 
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            Table-I Description of the sequences considered for checking the variance.  
No. Accession No. Description 
1 AF004885.1 HIV-1 isolate Q23-17 from Kenya, complete genome. 
2 AF005494.1 HIV-1 isolate 93br020 from Brazil complete genome. 
3 AF033819.3 HIV-1, complete genome  
4 AF042100.1 HIV-1 isolate MBC200 from Australia, complete genome. 
5 AF049337.1 HIV-1 clone 94CY032-3 from Cyprus, complete genome. 
6 AF061640.1 HIV-1 isolate HH8793 clone 1.1 from Finland, complete genome. 
7 AF063223.1 HIV-1 isolate DJ263 from Djibouti, complete genome. 
8 AF064699.1 HIV-1 isolate BFP90 from Burkina Faso, complete genome. 
9 AF067154.1 HIV-1 isolate 301999 from India, complete genome. 
10 AF069140.1 HIV-1 isolate DH12 clone 3 from the USA, complete genome. 
11 AF069671.1 HIV-1 isolate SE7535 from Uganda, complete genome. 
12 AF070521.1 HIV-1 E9 from the USA, complete genome. 
13 AF076474.1 HIV-1 isolate VI354 from Gabon, complete genome. 
14 AF084936.1 HIV-1 subtype G, Democratic Republic of the Congo, complete genome 
15 AF086817.1 HIV-1 strain LM49 isolate TWCYS from Taiwan, complete genome. 
16 AF115393.1 Simian immunodeficiency virus strain SIVcpz, complete genome. 
17 AF164485.1 HIV-1 isolate 93TH902.1 from Thailand, complete genome. 
18 AF179368.1 HIV-1 strain GR17 from Greece complete genome. 
19 AF193277.1 HIV-1 isolate RU98001 from Russia, complete genome. 
20 AF197340.1 HIV-1 isolate 90CF11697, Central African Republic, complete genome 
21 AF224507.1 HIV-1 strain HIV-1wk from Korea, complete genome. 
22 AF256205.1 HIV-1 clone S61D15 from Spain, complete genome. 
23 AF286225.1 HIV-1 strain 96ZM751 from Zambia, complete genome. 
24 AF286226.1 HIV-1 strain 97CN001 from China, complete genome. 
25 AF286227.1 HIV-1 strain 97ZA012 from South Africa, complete genome. 
26 AF286233.1 HIV-1 strain 98IS002 from Israel, complete genome. 
27 AF290028.1 HIV-1 clone C.96BW06.J4 from Botswana, complete genome. 
28 AF332867.1 HIV-1 isolate A027 from Argentina, complete genome. 
29 AF385934.1 HIV-1 isolate URTR23 from Uruguay, complete genome. 
30 AF413987.1 HIV-1 isolate 98UA0116 from Ukraine, complete genome. 
31 AF465242.1 Simian-Human immunodeficiency virus isolates 1B3, complete genome. 
32 AY586540.1 HIV-1 isolate CU76 from Cuba, complete genome. 
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3.2. Homology modeling and structure analysis 
 The protein structure databases were searched for the protein consensus sequence 
using BLAST and PSI-BLAST. Initial sequential similarity of each modified consensus 
sequence with sequence of the structures was carried out by ClustalX. Residue-by-residue 
geometry and overall structure geometry was analyzed for checking stereo chemical 
quality of downloaded protein data bank structures by Procheck [79]. Protein template for 
homology modeling was selected considering the overall structural quality and sequential 
and structural similarity with the consensus sequences. Blast [80] search among the 
proteins of known 3D structure revealed that the three structures from protein data base 
1tac, 1tbc and 1tiv showed the considerable sequence identity score with our sequences. 
Out of these structures 1tac misses crucial cystein residues and 1tiv scores very less in 
stereo chemical quality. Hence, in this study NMR structure of Tat (PDB code: 1tbc) [47] 
was selected as a template and based on this structure the 3D consensus structures were 
predicted. 
The alignment of the sequences with the template structure was done using Bodil 
[81].  The structures were generated from the sequence alignment and the structural 
template using the Modeler program (http://salilab.org/modeller) [82]. The computed 
structure of the Tat obtained was refined by energy minimization with NAMD 2.5 
(http://www.ks.uiuc.edu/Research/namd) [83] for 10 ps with restraint on the backbone of 
the protein taking CHARMM force field until the energy showed stability in sequential 
repetition. 
The conformational stability of the so predicted theoretical model was evaluated 
sterically with Procheck [79]. The modeled structures are visualized and structurally by 
Chimera [84]. The hydrogen interactions are predicted with constraint 0.4A and angle 20 
degree. 
3.3. Molecular dynamics simulation 
Molecular dynamics simulations of the modeled proteins are were performed 
using NAMD 2.5. The protein was immersed in a rectangular box of TIP3P waters [85] 
providing a 5 Å buffer from the protein to the periodic boundary in each direction. The 
bonded interactions were calculated at every time-step, the short-range nonbonded 
interactions at every two time-steps, and the long-range electrostatics interactions at 
every four time-steps. The pair-list of the non-bonded interaction was recalculated every 
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20 time-steps with a pair-list distance of 13.5 Å. The short-range non-bonded interactions 
were defined as Van der Waals and electrostatics interactions between particles within 12 
Å. A smoothing function was employed for the Van der Waals interactions at a distance 
of 10Å. The long range electrostatic forces were calculated with the particle-mesh Ewald 
[86]. CHARMM27 [87] force-field parameters were used in all simulations in this study. 
Periodic boundary conditions and water wrapping were activated in the simulations. The 
SHAKE routine with a tolerance of 10-8 Å was used in all simulations. In order to remove 
spurious contacts, a set of 13,000 energy minimization steps were carried out. The first 
3,000 steps were performed taking the protein backbone was fixed, minimizing all other 
atoms. No constraints were applied during the last 10,000 steps, freely minimizing all 
atoms. 
The system was simulated for with 1 atm constant pressure and 310K constant 
temperature (NPT) [88] using the Nose´-Hoover Langevin piston pressure control [89] 
and the Langevin damping dynamics [90] respectively. In next 400 ps the restraint on the 
protein backbone is removed completely in a stepwise manner. Then the system in is 
simulated without any restraint for 1600 ps continuously. So a simulation of 2 ns is 
achieved. The atomic coordinates and velocities were saved every 500 time-steps, and 
coordinate trajectories were saved every 250 time-steps for subsequent data analysis. It 
took approximately two day to achieve 1 ns simulation for the system using eight 1.15-
GHz EV7 processors on the HP micro tower.  
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Chapter 4 
4. Results and Discussion 
4.1. Sequence divergence  
   The alignment shows the sequence variability of the tat protein across the 
geographical distribution. The phylogenetic tree in figure is showing three branches on 
the basis of amino acid sequence similarity. The first branch consists up of sequences 
from Brazil, Uruguay, and Argentina. In the second branch sequences from countries 
Taiwan, Australia, Spain, USA, Russia, and Korea are segregated. All other sequences 
are grouped under the third branch. The sequence from the cpzsiv can be clearly seen as 
an out group. The consensus structures conceived in the study more or less represent each 
of these groups. 
 
Figure-8: Constructed phylogeny of the Tat data showing geographical variation. 
 The section wise variation of the residues in the protein sequences is shown in the 
table-II. Residues from position 1 to position 40 are moderately conserved with most of 
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the positions are highly conserved and some are partially conserved with strong or weak 
groups for substitution. The cystein residues are highly conserved as they are part of 
structurally important sulphur bonds. The core region (aa 38–48), which is highly 
conserved among other lentiviruses also shows high degree of conservancy.   
Table-II: Conservancy of amino acid positions across the sequences. Partially conserved 
groups are all the positively scoring groups that occur in the Gonnet Pam250 matrix. The 
strong and weak groups are defined as strong score >0.5 and weak score =<0.5 
respectively. 
Sequence Conserved Partially 
Conserved 
Sequence Conserved Partially 
Conserved 
Strong 
gr. 
Weak 
gr. 
  Strong 
gr. 
Weak 
gr. 
1-10 1,5,6,8,10 2,4,9 - 51-60 51-3,55, 
56 
- - 
11-20 11,14-5, 
18,20 
13,17 16 61-70 - 66 65 
21-30 21,25,27. 
28,30 
26 23 71-80 72 72,79 - 
31-40 33,34,37, 
38 
- 40 81-86 - 82,85,86 83,84 
41-50 41,42-50 - 43     
  
 The basic ARD region (aa 48-56) contains the nuclear localization signal of the 
protein [91] and specifically interacts with a uridine-rich bulge motif in the RNA TAR 
[48]. So, it shows high conservancy for maintaining functional viability of the protein. 
The core region, which has been proposed to provide structural stabilization to the protein 
[92] is least conserved. The structural stability, which is mostly dependent on residual 
interactions, is maintained in expense of the residual substitution and in favor of stronger 
interaction. The residues from 81 to 86 are moderately conserved. 
 Three consensus sequences are formed based on the position specific variability 
of the residues. The positional variations of the residues among the models are shown in 
table-III. As expected the variations are mainly concentrated at first and last sections of 
30 
 
the sequences. Out of 13 positional variations studied, the first eight (aa 3-35) show 
residual substitution within strong groups (Table-II). These positions are inside the region 
important for maintaining the functional viability of the protein. Any distant substitution 
with unrelated amino acid may disrupt the activity. The distance between the sequences is 
shown in the table IV. The sequence SA and C are maximum apart where as sequence SA 
and B are least apart. As the SA is modeled on the sequences from South America and 
the model B chiefly represents the sequences from Europe and North America the 
similarities are justified. 
Table-III: Variation of amino acid positions across the modeled structures. 
   
 Models 
positions 
3 7 12 19 21 23 24 35 61 64 67 68 77 
  SA L N N T P T R Y N T V S T 
   B P N N K A T N Q N T V S P 
   C P R K K A N K Q S D N P T 
 
Table-IV: Distance between the modeled sequences calculated by Protdist. 
 Distance 
Models SA B C 
SA 0 0.0914 0.184 
B 0.0914 0 0.125 
C 0.184 0.125 0 
 
4.2. Structural variability 
 
Figure-9: The Tat consensus structures from 32 protein sequences (Table-I) modeled on 
PDB: 1tbc. The helix 1 (blue) and helix 2 (green) are clearly visualized. 
 The structures though modeled on same template show structural v
Although Tat does not present secondary structure elements [
minimization show the two helical regions (Figure
positions 16S to 20T (Figure
interaction between 16S and 20T. Extra
and 82T, 16S and 82T, 21A and 23T, 19K and 25C.  Though a helical structure is formed 
between 15G to 21A the helix is not distinct in model C. In the helical s
hydrogen interaction between 16S and 20T, 16S and 21A. Extra
interactions are in between 16S and 82T, 14P and 82T, 20T and 23N, 19K and 28K.  
Lysine at position 19 forms a hydrogen interaction with 64D. Availability of 
position is the distinctive feature of C model and may be responsible for the splintering of 
helix. In model SA the helix is stabilize by the hydrogen interactions between 15G and 
19T, 16S and 20T. Extra-
and 82T, 18P and 23T. The residues at position 23, 25, 64, 84 are important for 
maintenance of helix structure. 
 Figure-10: A view of the first helix (residue ~16
their hydrogen interactions (
The second characteristic helix positions itself in between 25 to 29 amino acids 
(Figure-11). In model B the helix consists of amino acid of 27 to 29 positions. Secondary 
structure prediction also confirms formation of helix in this region (unpublished data). 
The helix is stabilized by the hydrogen interaction between 27C and 30C. There are 
hydrogen interactions between 27C and 32Y, 30C and 32Y, 28K and 25C, 29K and 25C.  
This shows the role of 25C and 32Y in stabilization of the helix. In model C a distinct 
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and well defined helix is formed though the residues 25 to 29. Intra helix hydrogen 
interactions can be seen between 24K and 28K, 25C and 29K, 26Y and 30C. Other 
hydrogen interactions are in between 23N and 19K, 28K and 19K. The lower part of the 
helix is forming hydrogen interactions as 28K and 32Y, 30C and 32Y. In model SA the 
helix consists of 26 to 29 residues. The helix is stabilized by the hydrogen interaction 
between 25C and 29K, 26Y and 30C. There is a hydrogen interaction in between 24R and 
26Y is essential for formation of helix. 
 
Figure-11: The view of second helix (residue ~ 26-30) of the consensus structures and 
their hydrogen interactions (pink lines) with other neighboring residues. 
 Churcher et al. have demonstrated the importance of sequence from position 48G 
to 59P in recognition and attachment to the TAR RNA element [93]. The arrangement of 
these residues and their hydrogen interaction formation with the neighboring residues can 
be visualize by table-V. The motif is stabilized by hydrogen interactions with some of the 
distant residues like 2E, 5D, 9E, 35Q, 44G. The glutamine residue at position 54 which 
takes a crucial role in binding to TAR RNA element shows highest number of hydrogen 
interactions. The arginine rich central part aa (52-57) also shows higher number of 
hydrogen interactions. The interaction between the basic region and the glutamic acid 
residue at position 2 as described by Pantano et al. can be clearly visualized [54].  
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Table-V: Hydrogen interactions formed in the RNA binding motif (48-59) across the 
models. The interaction (H.B) is shown between the residues (res.) among the models. 
B C SA 
Res. H.B Res. H.B Res. H.B 
48G  48G  48G 50K 
49R 44G(2), 33H(2) 49R 44G, 32Y,67N 49R 44G(2) 
50K 52R, 2E 50K 52R 50K 48G, 2E 
51K  51K 53R, 54Q(2) 51K  
52R 50K,54Q,55R 52R 50K 52R 54Q, 55R 
53R 54Q, 35Q 53R 51K, 35Q 53R 54Q 
54Q 52R, 53R,57R 54Q 51K, 56R 54Q 52R,53R, 56R 
55R 5D 55R 5D 55R 52R, 5D 
56R 9E 56R 54Q, 9E, 63Q 56R 54Q, 9E 
57R 54Q 57R 60Q 57R 68S 
58T  58T  58T  
59P  59P 63Q 59P 65H 
4.3. Dynamics of residue patches and active pockets 
  Three molecular dynamics simulations of two nanosecond each were carried out 
on the models in order to investigate their stability and dynamical properties. Each 
systems were simulated without constraints and reached equilibrium after approximately 
1.2 ns of constant pressure and temperature equilibration at 1 atm and 310 K. 
Correspondingly, the trajectory time from 0–1.2  ns is referred to as the “equilibration 
phase” and from 1.2–2 ns is referred to as the ‘‘dynamics phase’’ (Figure-12). Plots of 
the time evolution of the root mean square deviation (RMSD), where each trajectory 
frame was aligned to the initial starting structure in order to remove any rotational or 
translational motion, indicate that equilibration was achieved for all systems. The overall 
root-mean-square-fluctuations (RMSF) per residue was calculated during the dynamics 
phase for each system based on Cα positions after alignment to the average equilibrated 
structure, and the resulting RMSF difference plot shows the differences in RMS 
fluctuations between the three systems (Figure-13). The average RMSFs of the residues 
of models B, C and SA is 2.18, 1.16 and 1.48 respectively. 
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Figure-12: Root mean square deviation (RMSD) of the models plotted as a function of 
simulation time of 2 ns.  
Position of the residue and its interaction with other residues defines the structure 
of the protein and also characterize its molecular dynamics motion. Residues adjacent to 
glycine and proline show marked motion due to their conformational flexibility. The 
presence of 5’GLGI3’ motif in between position 42 to 45 explains the increased 
fluctuation of this region (Figure-13). The role of this region as a hinge between the 
trans-activating core region and RNA binding ARD can be reasoned for this dynamics.  
The location of polar uncharged amino acid aspargine at position 24 in model B instead 
of a basic amino acid lysine and arginine as in model C and SA is responsible for 
increased fluctuation of the residues near to the said position. 
 
Figure-13: Structural flexibility shown as RMSFs of all Cα atoms of the models from the 
last 800 ps of unrestrained simulations. 
The residues from 48G to 59P consisting the RNA binding arginine rich domain 
(ARD) are showing least motion as compared to other residues (Figure-14b). This pocket 
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as a motif is stabilized by various hydrogen interactions with neighbor residues (Table-
V). The arginine at 52 in model C shows increased motion due to lesser number of 
hydrogen interactions as compared to other structures. The exact opposite can be applied 
for arginine at position 56 as it shows less motion in model C as compared to other 
models. Glutamine at position 53, a very important residue in binding to TAR RNA 
shows less motion as it is well stabilized by hydrogen interactions with other residues. 
The residues 2E, 5D, 9E, 33H, 44G which are important for maintaining the RNA 
binding pocket (Table-V) are showing reduced motion as compared to other residues. 
This is to conserve the structure of the protein for functional viability.  
Table-VI: Comparisons of residual variations (RMSFs) of Cα atoms of the models at 
selected positions (Table-III) from the last 800 ps of unrestrained simulations. 
Res.No. 
Models 
SA B C 
3 L 1.949309 P 1.375736 P 1.263088 
7 N 2.631948 N 2.312005 R 1.634231 
12 N 2.123034 N 1.804578 K 0.939108 
19 T 2.269854 K 1.74876 K 1.092498 
21 P 2.59306 A 1.891883 A 1.247441 
23 T 2.987654 T 2.055694 N 2.280313 
24 R 3.272842 N 1.498669 K 1.679775 
35 Y 2.340913 Q 1.024713 Q 1.050018 
61 N 1.746667 N 1.392315 S 1.869763 
64 T 1.303023 T 0.705819 D 0.923727 
67 V 1.432402 V 0.835493 N 1.279583 
68 S 1.407785 S 1.05363 P 1.123748 
77 T 2.350838 P 1.603655 T 1.144498 
 Considering the taken residual variations among the models (Table-III) the 
RMSFs of residues at each position across the models are given in Table-VI.  The 
RMSFs for the similar residues among the models at a position are almost equal in the 
NT and CRT region (positions in between 3 to 35). But it is not true for residues in QRD 
and CT where the interactions rather than nature of the nature of the residue are vital for 
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maintaining the stability of the protein. In these regions the models though contain 
similar residues show dissimilar RSMFs and vice versa. 
 
 
(c) 
Figure-14: Variation in average fluctuation (RSMF) of Cα atoms of residues constituting 
(a) helical domains (b)  Arginine Rich Domain (ARD), cystein residues and (c) all 
structural domains of Tat protein across the models from the last 800 ps of unrestrained 
simulations. Hel1: Helix1 (residue16-20), Hel2: Helix2 (residue26-30), ARD: Arginine 
Rich Domain (residue48-59), CysRes: Cystein Residues, All-Hel1, All-Hel2, All-ARD, 
All-CysRes: All other residues except those of respective structural domains. 
The QRD which has been proposed to provide structural stabilization to the 
protein [92], is showing almost homogeneous variation though out the models (Figure-
13). The reverse is true for the cysteine-rich domain (aa 22–37) and the core region (aa 
38–48) rich in hydrophobic residues this region is crucial for Tat trans-activation [48, 92] 
which have a varying RMSF for the residues (Figure-14b). Though the domains have a 
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varied motion with a diverse average RMSF in a protein structure, they maintain a 
specific homogeneity when compared across the models. The second helix in the core 
region always shows the highest RMSF where as the ARD shows the lowest (Figure-14c) 
though out the models. Similarly the model B shows highest and model SA shows the 
lowest deviation when the domains are considered (Figure-14a, b). 
The helix 1 which comprises of roughly residue 16S to residue 19 shows minimal 
motion across the models with average RMSF of 1.085 in SA, 2.045 in B and 1.685 in C 
(Figure-14c). Notably, the helix-1 exhibits marked stability with lower RMSF (Figure-
14a) as compared to rest of the residues. There is an increased RMSD after disruption of 
the helix from position 21. In model C where the helix-2 is not well defined the residues 
have an increased RMSF of 2.43 compared to other models at those positions. The 
residues of helix2 which are positioned roughly from 26 to 29 have an increased motion 
as compared to helix 1 due to its undefined nature except model C. In model C where it 
has a very stable conformation the residues have a lower average RMSF of 1.9 compared 
to other models. The position of this structure in the catalytically dynamic core region 
also explains the increased fluctuation.  
 
Figure-7/15: Total energy (E) of the models plotted as a function of simulation time 
indicated as number of time steps (TS).  
Average total energy of the models during the simulation is shown in the figure-
15. Though models SA and C show distant sequence similarity (table-IV) their average 
energy is almost equal. Similarly sequential most similar models SA and B are showing a 
large difference in their total energy. The increased RMSF of the residues of model B 
coincides with the maximum total energy among the models. It shows the structure B is 
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less stable than other two models. It may be noted that the energy of a molecule is more 
dependent on its structure and various interactions than its sequence. 
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Chapter 5 
5. Conclusion 
Human immunodeficiency virus (HIV) is a retrovirus that causes acquired 
immunodeficiency syndrome.  The life cycle of HIV inside the human host is complex 
and precise consisting many macromolecular interactions and activations. Each function 
is the window to next function performing role of molecular check point. Inhibiting one 
step effects the next impeding the cycle of viral replication and function.  
The structural basis for cyclin T1 interaction with Tat and TAR is still unclear. 
Cyclin T1 is believed to interact with Tat through metal ions stabilized by essential 
cysteine residues found in both proteins [94, 95]. Since the cysteine-rich and hydrophobic 
regions of the free Tat protein are highly flexible, it seems likely that they undergo 
conformational rearrangements during assembly of the ternary complex with cyclin T1. 
The TAR RNA binding motif shows less structural dynamics and more conformational 
stability (Figure-14b, Table-V). This may be the requirement for steady binding to the 
RNA element. Again any change in core region shows decreased in stability. Taking the 
model B which had more deviations in its core region (21-47) is least stable as it has 
maximum total energy (figure-15). The reverse is true for the model SA where lesser 
RMSD across the residues in this region shows higher stability of protein when energy is 
considered. The role of the hydrogen interactions for maintaining functional and 
structural viability of the protein is also clearly demonstrated (Table-V). Our study 
defines three regions in Tat protein structure. The first region consists of residues 1 to 47 
and vital for various catalytic function of the protein. This region is characterized by 
minimal substitution or substitution by near group residues (Table-II, III), presence of 
structural motifs for molecular recognition (Figure-10, 11) and high motion (Figure-13). 
The second region (aa 48-59), which is responsible for RNA binding, shows no residual 
variation (Table-II) and minimal molecular dynamics motion (Figure-6b, c). The region 
is quite stable with many hydrogen interactions (Table-V). In the third region (aa 60-86) 
the residual interactions takes the central role in place of residue itself (Table-VI). The 
region has a stable conformation with least residual fluctuations (Figure-13). 
 Our results indicate that the presence of hydrogen interactions appreciably affects 
the system dynamics, providing stabilization to some regions of the protein structure, 
while causing increased fluctuations in other areas where the residues are not stabilized 
by it. In addition to this residual position and the role of the domain in function of the 
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protein can be suitably correlated to the residual motion during molecular dynamics 
simulation. The study also explains the pre binding stability of the active site of Tat 
protein which is crucial for its intended function. Structural and sequential analysis of the 
macromolecules both with time and conditional variance is needed for measuring the 
state of variability of each molecule. Then relating these to the interaction data will 
certainly point out the conserved sequential stages the viral progression. Then these 
stages can be examined for inhibitory suitability by different ligands or other variables. 
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Appendix1 
Codes for structural modeling 
# Homology modeling by the automodel class 
from modeller import *                       # Load standard Modeller classes 
from modeller.automodel import *    # Load the automodel class 
 
log.verbose()      # request verbose output 
env = environ()  # create a new MODELLER environment to build this model in 
 
# directories for input atom files 
env.io.atom_files_directory = './:../atom_files' 
 
a = automodel(env, 
                         alnfile  = '1tbc_c.ali',         # alignment filename 
                         knowns   = '1tbc',              # codes of the templates 
                         sequence = 'C')                  # code of the target 
a.starting_model= 1                   # index of the first model  
a.ending_model  = 1                  # index of the last model 
                                           # (determines how many models to calculate) 
a.make()                            # do the actual homology modeling 
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Appendix2 
Codes for molecular dynamics simulation 
1) Psfgen file 
package require psfgen 
topology top_all27_prot_lipid.inp 
pdbalias residue HIS HSE 
pdbalias atom ILE CD1 CD 
segment U {pdb 1tbc_cp.pdb} 
coordpdb 1tbc_cp.pdb U 
guesscoord 
writepdb 1tbc_c.pdb 
writepsf 1tbc_c.psf 
2) Water sphere file 
### Script to immerse ubiquitin in a sphere of water just large enough  
### to cover it 
 
set molname 1tbc_c 
 
mol new ${molname}.psf 
mol addfile ${molname}.pdb 
 
### Determine the center of mass of the molecule and store the coordinates 
set cen [measure center [atomselect top all] weight mass] 
set x1 [lindex $cen 0] 
set y1 [lindex $cen 1] 
set z1 [lindex $cen 2] 
set max 0 
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### Determine the distance of the farthest atom from the center of mass 
foreach atom [[atomselect top all] get index] { 
  set pos [lindex [[atomselect top "index $atom"] get {x y z}] 0] 
  set x2 [lindex $pos 0] 
  set y2 [lindex $pos 1] 
  set z2 [lindex $pos 2] 
  set dist [expr pow(($x2-$x1)*($x2-$x1) + ($y2-$y1)*($y2-$y1) + ($z2-$z1)*($z2-$z1),0.5)] 
  if {$dist > $max} {set max $dist} 
  } 
 
mol delete top 
 
### Solvate the molecule in a water box with enough padding (15 A). 
### One could alternatively align the molecule such that the vector  
### from the center of mass to the farthest atom is aligned with an axis, 
### and then use no padding 
package require solvate 
solvate ${molname}.psf ${molname}.pdb -t 15 -o del_water 
 
resetpsf 
package require psfgen 
mol new del_water.psf 
mol addfile del_water.pdb 
readpsf del_water.psf 
coordpdb del_water.pdb 
 
### Determine which water molecules need to be deleted and use a for loop 
### to delete them 
set wat [atomselect top "same residue as {water and ((x-$x1)*(x-$x1) + (y-$y1)*(y-$y1) 
+ (z-$z1)*(z-$z1))<($max*$max)}"] 
set del [atomselect top "water and not same residue as {water and ((x-$x1)*(x-$x1) + (y-
$y1)*(y-$y1) + (z-$z1)*(z-$z1))<($max*$max)}"] 
set seg [$del get segid] 
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set res [$del get resid] 
set name [$del get name] 
for {set i 0} {$i < [llength $seg]} {incr i} { 
  delatom [lindex $seg $i] [lindex $res $i] [lindex $name $i]  
  } 
writepsf ${molname}_ws.psf 
writepdb ${molname}_ws.pdb 
 
mol delete top 
 
mol new ${molname}_ws.psf 
mol addfile ${molname}_ws.pdb 
puts "CENTER OF MASS OF SPHERE IS: [measure center [atomselect top all] weight 
mass]" 
puts "RADIUS OF SPHERE IS: $max" 
mol delete top 
3) Minimization file 
############################################################# 
## JOB DESCRIPTION                                         ## 
############################################################# 
 
# Minimization of tat in a Water Box 
 
############################################################# 
## ADJUSTABLE PARAMETERS                                   ## 
############################################################# 
 
structure             ../common/b/1tbc_b_wb.psf 
coordinates        ../common/b/1tbc_b_wb.pdb 
 
set temperature    310 
set outputname     b_min 
firsttimestep         0 
 
############################################################# 
## SIMULATION PARAMETERS                                   ## 
############################################################# 
# Input 
paraTypeCharmm     on 
parameters          ../common/b/par_all22_prot_cmap.inp  
temperature         $temperature 
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# Force-Field Parameters 
exclude             scaled1-4 
1-4scaling          1.0 
cutoff                 12. 
switching           on 
switchdist          10. 
pairlistdist        13.5 
 
# Integrator Parameters 
timestep                  1.0  ;# 2fs/step 
nonbondedFreq        2 
fullElectFrequency  4   
stepspercycle           20 
   
# Periodic Boundary Conditions 
cellBasisVector1    47.6   0.   0. 
cellBasisVector2     0.   42.7  0. 
cellBasisVector3     0.    0   36.9 
cellOrigin            -5.0  -0.85  5.3 
wrapAll             on 
 
# PME (for full-system periodic electrostatics) 
PME                        yes 
PMEGridSizeX        48 
PMEGridSizeY        45 
PMEGridSizeZ        40 
 
# Constant Pressure Control (variable volume) 
useGroupPressure      yes ;# needed for rigidBonds 
useFlexibleCell         no 
useConstantArea       no 
 
langevinPiston             on 
langevinPistonTarget  1.01325 ;#  in bar -> 1 atm 
langevinPistonPeriod  100. 
langevinPistonDecay   50. 
langevinPistonTemp    $temperature 
 
constraints on 
consref    ../common/b/1tbc_b_wb.pdb 
conskfile ../common/b/1tbc_b_wb.pdb 
conskcol B 
constraintScaling 1 
# Output 
outputName          $outputname 
 
restartfreq         500     ;# 500steps = every 1ps 
dcdfreq             500 
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xstFreq             250 
outputEnergies      100 
outputPressure      100 
 
############################################################# 
## EXECUTION SCRIPT                                        ## 
############################################################# 
 
# Minimization 
minimize            3000 
reinitvels          $temperature 
          
4) Parameter file for simulation 
############################################################# 
## JOB DESCRIPTION                                         ## 
############################################################# 
 
# Simulation of Tat 
 
############################################################# 
## ADJUSTABLE PARAMETERS                                   ## 
############################################################# 
 
structure             ../common/c/1tbc_c_wb.psf 
coordinates        ../common/c/1tbc_c_wb.pdb 
outputName         c_eq1 
 
# set temperature    310 
 
# Continuing a job from the restart files 
if {1} { 
set inputname        c_min 
binCoordinates     $inputname.restart.coor 
binVelocities        $inputname.restart.vel  ;# remove the "temperature" entry if you use this! 
extendedSystem    $inputname.xsc 
}  
firsttimestep      0 
 
############################################################# 
## SIMULATION PARAMETERS                                   ## 
############################################################# 
 
# Input 
paraTypeCharmm     on 
parameters          ../common/c/par_all22_prot_cmap.inp  
 
# NOTE: Do not set the initial velocity temperature if you  
# have also specified a .vel restart file! 
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# temperature         $temperature 
  
wrapWater           on 
wrapAll             on 
 
# Force-Field Parameters 
exclude             scaled1-4 
1-4scaling          1.0 
cutoff                 12. 
switching           on 
switchdist          10. 
pairlistdist        13.5 
 
 
# Integrator Parameters 
timestep                 1.0  ;# 2fs/step 
nonbondedFreq        2 
fullElectFrequency  4   
stepspercycle          20 
 
 
 
# Constant Temperature Control 
langevin                   on    ;# do langevin dynamics 
langevinDamping     5     ;# damping coefficient (gamma) of 5/ps 
langevinTemp        310 
langevinHydrogen    no    ;# don't couple langevin bath to hydrogens 
 
 
# Constant Pressure Control (variable volume) 
useGroupPressure      yes ;# needed for 2fs steps 
useFlexibleCell          no  ;# no for water box, yes for membrane 
useConstantArea        no  ;# no for water box, yes for membrane 
 
langevinPiston            on 
langevinPistonTarget  1.01325 ;#  in bar -> 1 atm 
langevinPistonPeriod  100. 
langevinPistonDecay   50. 
langevinPistonTemp    310 
 
constraints on 
consref    ../common/c/1tbc_c_wb.pdb 
conskfile ../common/c/1tbc_c_wb.pdb 
conskcol B 
constraintScaling 1.0 
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restartfreq              500     ;# 500steps = every 1ps 
dcdfreq                  500 
xstFreq                  250 
outputEnergies      100 
outputPressure      100 
 
 
############################################################# 
## EXECUTION SCRIPT                                        ## 
############################################################# 
 
run 500000 ;# 50ps 
 
